Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: Pooled Patient-Level Analysis From the HORIZONS-AMI and EUROMAX Trials.

Stone, GW; Mehran, R; Goldstein, P; Witzenbichler, B; Van't Hof, A; Guagliumi, G; Hamm, CW; Généreux, P; Clemmensen, P; Pocock, SJ; +4 more... Gersh, BJ; Bernstein, D; Deliargyris, EN; Steg, PG; (2014) Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: Pooled Patient-Level Analysis From the HORIZONS-AMI and EUROMAX Trials. Journal of the American College of Cardiology, 65 (1). pp. 27-38. ISSN 0735-1097 DOI: https://doi.org/10.1016/j.jacc.2014.10.029

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.jacc.2014.10.029

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar